Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy

Jim, Heather S LHeather S LJimPhillips, Kristin MKristin MPhillipsChait, SariSariChaitFaul, Leigh AnneLeigh AnneFaulPopa, Mihaela AMihaela APopaYUN-HSIANG LEEHussin, Mallory GMallory GHussinJacobsen, Paul BPaul BJacobsenSmall, Brent JBrent JSmall2023-05-302023-05-302012-10-100732-183Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/631541Evidence is mixed regarding long-term cognitive deficits in patients treated with chemotherapy. Previous meta-analyses have not focused specifically on the postchemotherapy period and have not incorporated several recent studies. The goal of the current study was to conduct a meta-analysis of cognitive functioning in breast cancer survivors who were treated with chemotherapy ≥ 6 months previously.enRECEIVING ADJUVANT CHEMOTHERAPY; QUALITY-OF-LIFE; LONGITUDINAL ASSESSMENT; MENOPAUSAL SYMPTOMS; PUBLICATION BIAS; FOLLOW-UP; WOMEN; IMPAIRMENT; THERAPY; FATIGUE[SDGs]SDG3Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapyreview10.1200/JCO.2011.39.5640229275262-s2.0-84867610331WOS:000309653600007https://api.elsevier.com/content/abstract/scopus_id/84867610331